Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dark Chocolate Reduces ACE Activity and May Lower Heart Attack Risk

By LabMedica International staff writers
Posted on 01 Dec 2010
Eating as little as 75 grams of dark chocolate reduces the activity of angiotensin-converting enzyme (ACE) while increasing levels of nitric oxide (NO), which suggests that including chocolate in the diet may ultimately help reduce hypertension and its related risk of cardiovascular disease.

Investigators at Linköping University (Sweden) wanted to determine if cocoa extract and dark chocolate would influence ACE and NO in human endothelial cells (in vitro) and in healthy volunteers (in vivo). More...


ACE activity was analyzed with a commercial radioenzymatic assay and measured in human endothelial cells from umbilical veins (HUVEC) after a 10-minute incubation with cocoa extract. NO was measured after 24 hours incubation. In 16 healthy volunteers ACE activity and NO were measured at baseline and after 30, 60 and 180 minutes after a single intake of 75 g dark chocolate containing 72% cocoa. The volunteers were not tobacco users and were not allowed to take any pharmaceuticals for the two weeks prior to the experiment. During the last two days, they were not allowed to eat chocolate or any foods containing similar compounds, including many kinds of berries and fruits, nor could they drink coffee, tea, or wine.

Results published in the October 14, 2010, online edition of the Journal of Cardiovascular Pharmacology revealed that in the HUVEC significant inhibition of ACE activity and significant increase of NO were seen. In the human volunteers, a significant inhibition of ACE activity (mean 18%) three hours after intake of dark chocolate was measured, but no significant change in NO was seen.

"We have previously shown that green tea inhibits the enzyme ACE, which is involved in the body's fluid balance and blood pressure regulation. Now we wanted to study the effect of cocoa, since the active substances catechins and procyanidines are related,” said first author Dr. Ingrid Persson, professor of pharmacology at Linköping University. "Our findings indicate that changes in lifestyle with the help of foods that contain large concentrations of catechins and procyaninides prevent cardiovascular diseases.”

Related Links:
Linköping University


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.